骨髄線維症悪性幹細胞の機能維持に不可欠な微小環境細胞間相互作用
Min Lu1, Md Babu Mia1, Lijuan Xia2
1Icahn School of Medicine at Mount Sinai, New York, New York, United States.
Blood
|December 15, 2025
まとめ
がん幹細胞(CSC)は腫瘍微小環境(TME)との相互作用によってがんを促進します。この研究は骨髄線維症(MF)幹細胞/TME相互作用をモデル化し、重要な炎症促進応答と悪性クローン優位性の維持を明らかにしました。
科学分野:
- 血液学
- がん生物学
- 幹細胞研究
背景:
- がんの進行は、がん幹細胞(CSC)と腫瘍微小環境(TME)との相互作用の影響を受けます。
- 骨髄線維症(MF)は、CSCがTMEと相互作用する幹細胞駆動性の骨髄増殖性腫瘍です。
研究 の 目的:
- in vivoのがん幹細胞/TME相互作用のモデルを開発すること。
- 悪性MF造血幹細胞および前駆細胞(HSPC)と非悪性TME細胞(内皮細胞[EC]および間葉系幹細胞[MSC])との相互作用の機能的結果を調査すること。
主な方法:
- MF HSPCと正常ドナーECおよびMSCを共培養して三者培養システムを作成しました。
- 共培養されたMF HSPCを免疫不全マウスに移植して、MF表現型の再現性を評価しました。
- 共培養細胞の転写プロファイリングを実施して、分子変化を同定しました。
主要な成果:
- 三者培養システムは悪性クローン優位性とMF HSPCの持続を促進しました。
- 共培養されたMF HSPCは、移植時に脾腫や骨髄線維症を含むMF表現型を再現しました。
- 転写プロファイリングにより、MF HSPC、MSC、ECの再プログラミングが明らかになり、炎症促進経路の顕著な上方制御が認められました。
結論:
- このヒト多細胞モデルは、MF HSPCとTME細胞間の多方向相互作用を効果的に実証しました。
- これらの相互作用は、完全に機能的なMF幹細胞を維持するために不可欠です。
- 本研究は、CSC/TME相互作用によって駆動されるMF病因における炎症促進応答の重要な役割を強調しています。
関連する概念動画
Regulation of Hematopoietic Stem Cells
3.9K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.9K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Cancer Stem Cells and Tumor Maintenance
5.8K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.8K
Stem Cell Niche
6.2K
The stem cell niche is the dynamic microenvironment where stem cells reside. Inside these niches, the cells may remain undifferentiated, undergo high self-renewal, or become lineage-specific progenitors. Stem cells coexist with other niche cells, such as stromal cells. They also interact closely with the ECM. Cell-cell and cell-matrix communication occur via adhesion molecules or soluble factors that signal the stem cells and determine their fate. Stromal cells also provide survival signals to...
6.2K
Differentiation of Common Myeloid Progenitor Cells
3.9K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.9K
Mesenchymal Stem Cells
5.5K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.5K


